Belite Bio Inc ADR (BLTE : NASDAQ)
Common Stock
$158.59
USD
+4.10 (2.65%)
Last updated: 2026-10-12
Follow BLTE
BLTE
Belite Bio Inc ADR
WealthAwesomePerformance
1 Day
+2.65%
1 Week
-0.37%
1 Month
-8.75%
YTD
+6.91%
Key Statistics
Market Cap
$6.22B
52W High
$200.00
52W Low
$79.05
P/E Ratio
-
50 Day MA
$165.63
200 Day MA
$161.00
Beta
-1.23
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/12/2026 | $154.95 | $160.74 | $154.63 | $158.59 | $158.59 | 240,776 |
| 10/9/2026 | $152.73 | $155.99 | $152.17 | $154.49 | $154.49 | 179,300 |
| 10/8/2026 | $155.79 | $155.85 | $150.21 | $152.52 | $152.52 | 154,319 |
| 10/7/2026 | $155.09 | $156.75 | $154.60 | $156.08 | $156.08 | 97,801 |
| 10/6/2026 | $158.24 | $158.24 | $152.64 | $155.61 | $155.61 | 190,137 |
| 10/5/2026 | $160.00 | $160.00 | $156.40 | $159.18 | $159.18 | 133,263 |
| 10/2/2026 | $163.50 | $164.60 | $159.00 | $159.56 | $159.56 | 184,800 |
| 10/1/2026 | $168.98 | $170.36 | $162.98 | $162.98 | $162.98 | 198,812 |
| 9/30/2026 | $167.27 | $172.74 | $167.18 | $169.82 | $169.82 | 142,076 |
| 9/29/2026 | $166.72 | $169.52 | $164.41 | $166.66 | $166.66 | 138,673 |
Analyst Price Targets
Based on 9 analysts covering BLTE · as of Oct 5, 2026
Wall Street analysts forecast BLTE stock price to rise 44.3% over the next 12 months.
Consensus
Strong Buy4.78 / 5.00
Avg. Target
US$228.89
+44.3% Upside
Current Price
US$158.59
Last close
Analyst Breakdown (9 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLTE's historical volatility
30-Day Vol
53.0%
Annualized
90-Day Vol
48.5%
Annualized
Trend (90d)
+23.2%
Annualized drift
90d Mean
US$172.27
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$163.02 | US$135.79 – US$195.73 |
| 60 trading days | US$167.58 | US$129.40 – US$217.02 |
| 90 trading days | US$172.27 | US$125.51 – US$236.44 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Belite Bio Inc ADR
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-118.49M
- Profit Margin
- 0.00%
- ROE (TTM)
- -22.10%
- EPS (Diluted)
- -2.74
- Book Value
- 19.29
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About BLTE.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| MNDR | Mobile-health Network Solutions Class A Ordinary Shares | $3.04 | +257.65% |
| LNKS | Linkers Industries Limited Class A Ordinary Shares | $2.27 | +138.37% |
| YMAT | J-Star Holding Co., Ltd. Ordinary Shares | $2.91 | +125.58% |
| CLWT | Euro Tech Holdings Company Ltd | $2.15 | +58.09% |
| BMBL | Bumble Inc | $3.80 | +49.61% |
| SKYA | SkyAI, Inc. | $2.60 | +42.86% |
| WFF | WF Holding Limited Ordinary Shares | $17.28 | +40.60% |
| NCPL | Netcapital Inc | $1.54 | +35.09% |
BLTE.US news timeline
1 article covering BLTE.US, most recent first
Latest